Robert T. Brodell MD, FAAD
Professor and Chair, Department of Pathology; Past Founding Chair, Department of Dermatology; Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center, Jackson, MississippiAfter founding the Department of Dermatology at the University of Mississippi Medical Center in 2013, Dr. Robert T. Brodell is now tenured Professor and Chair of the Department of Pathology. His research focuses on human papillomavirus and translational research — moving science to the treatment room. His clinical interests include general dermatology, procedural dermatology, dermatopathology, and warts. In addition to his involvement in teaching, he has a strong interest in the ethics of dermatology, in tips and tricks for procedural dermatology, and in access to care in rural America. He also serves as a part-time staff physician at the Sonny Montgomery Veterans Administration Hospital in Jackson, Mississippi.
A dedicated teacher, he has performed almost 2000 lectures in his career and is the recipient of the Thomas G. Pearson, EdD, Memorial Education Award of the American Academy of Dermatology in 2018. He is also a dedicated volunteer for the American Cancer Society and a member of the Relay For Life Hall of Fame.
Dr. Brodell is an associate editor of the Journal of the American Academy of Dermatology, and he serves on the editorial boards of the American Medical Student Research Journal, where he is faculty advisor to the editorial board, Practical Dermatology, Journal of the Mississippi State Medical Society, and SKIN: The Journal of Cutaneous Medicine.
Disclosures
- Multicenter clinical trials: Novartis (principal investigator); CorEvitas (psoriasis biologic registry)
- Educational grant: Pfizer
Recent Contributions to PracticeUpdate:
- Photographing Lesions in Dermatology: Practical, Legal, and Technical Considerations
- Comparison of 10% Potassium Hydroxide Solution Versus Cryotherapy in the Treatment of Molluscum Contagiosum: An Open Randomized Clinical Trial
- 8 Changes I Made in My Clinical Practice in 2013
- Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011
- FDA Drug Safety Communication: FDA Limits Usage of Nizoral (Ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and Risk of Drug Interactions and Adrenal Gland Problems
- FDA Drug Safety Communication: FDA Limits Usage of Nizoral (Ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and Risk of Drug Interactions and Adrenal Gland Problems
- Bullous Pemphigoid as Pruritus in the Elderly: A Common Presentation
- Daily Sunscreen Use (> SPF 15) and Regular Reapplication Significantly Retarded Photoaging of the Skin
- Elderly Patients With Multiple Prurigo Nodules in Sun-Damaged Skin May Be Predisposed to Keratoacanthoma
- Vanity, Not Fear, Drives Sunscreen Use in Teens